Ed Yu

Health Industries Innovation & Business Design, PwC Strategy& Partner (retired), Chairman at Vascular Cures

[Matthew Corriere @MCorriereMD]

Outstanding presentation by @UMichSurgery @UoMVascSurgery resident Dr. Chloe Powell on patient reported outcomes @CBSSM #cbssm22 #bishoplecture

[Kevin Heath @KevinHeathMDMPH]

Our research identifies increased risk for MACE and mortality among PAD screened positive individuals, even those with no previous known cardiovascular disease. @JVascSurg @YaleVAMOS https://t.co/pVtTCbdWki

[Foundation to Advance Vascular Cures @VascularCures]

Vascular Cures is excited to announce two new health equity grants designed to advance transformative ideas that can “Promote Health Equity in Vascular Research & Care”.

Details here: https://t.co/KXVal3Je7I.

#VascularCures #CPCR #VascularDisease #PAD #CLTI #VascularHealth

[Foundation to Advance Vascular Cures @VascularCures]

Vascular Cures is very excited to announce Dr. Kevin Southerland, Assistant Professor of Surgery at Duke University @DukeSurgery, as the 2021 Wylie Scholar! Learn more about the award and his groundbreaking research here: https://t.co/f69Kcai6Nw

#WylieScholar #WylieScholarAward

[Ed Yu @edkyu2]

Funding is available for your innovative vascular research. Apply below. 👇

[Foundation to Advance Vascular Cures @VascularCures]

We're building a pipeline of innovators in vascular health. The Wylie Scholars program supports crucial research that helps advance new treatments and transform patient care. Apply for the 2021 award by March 1st: https://t.co/yy8erVn5Hl

[Foundation to Advance Vascular Cures @VascularCures]

How do we continue to advance vascular care despite a global pandemic? Vascular Cures Chairman @edkyu2 breaks down five trends driving vascular innovation in 2021 in this weeks Vascular innovation Spotlight: https://t.co/9NRbdfEwET

[Ed Yu @edkyu2]

How do you measure good (enough) health? It will take all of us to define this. You’re empowered to voice your opinion. @VascularCures is listening.

[Foundation to Advance Vascular Cures @VascularCures]

In the next episode of the Vascular Innovation Spotlight, @edkyu2 -- Chairman and former partner of PwC -- breaks down the importance of using patient voice throughout health innovation to achieve the ultimate goal: better patient outcomes. Full interview: https://t.co/rKaT827tf6

[Foundation to Advance Vascular Cures @VascularCures]

#PAD does not get better with time and there is no cure. However, there are several easy ways to prevent PAD. In honor of #PADawareness month, each week we will be highlighting different prevention methods. For more information, visit https://t.co/3HK7fAkiRo.

[Foundation to Advance Vascular Cures @VascularCures]

September is #PADAwareness month. Because patients are often asymptomatic at first, it's important to spread awareness about #PAD and know the warning signs and risk factors. Learn more on our website at: https://t.co/3HK7fAkiRo.

[Foundation to Advance Vascular Cures @VascularCures]

Vascular Cures is excited to announce our first annual 10 for 10 PAD Awareness Run/Walk! Join us in walking or running a virtual 10K over 10 days for the 10 million with Peripheral Artery Disease. Learn more and register at https://t.co/FW0CLYbQA0

[HealthDay News @wiseinvestinh]

There's been a significant drop in diabetes-related lower leg amputations among non-white patients in states that expanded Medicaid under Obamacare, a new study finds. @TzeWoeiTan @UofAZSurgery @AmDiabetesAssn https://t.co/ADkdYWXmrQ

[Foundation to Advance Vascular Cures @VascularCures]

In our latest news story, Dr. Andrea Obi (@AndreaObiMD), the 2019 #WylieScholar, shares her perspective on the current understanding of #COVID19’s impact on VTE and how her research may answer ongoing questions and lead to treatments. Read more at: https://t.co/MXyUyoz57e.

[Foundation to Advance Vascular Cures @VascularCures]

Our Spring Newsletter is here! Check out the latest Vascular Cures news, including messages from Chief Medical Officer Dr. Michael Conte and Chairman of the Board Ed Yu (@edkyu2): https://t.co/TnItejI8SZ.

[Darren Schneider, MD @VascularMD]

Yes, I doubt there's been a decrease in the incidence of vascular disease. We're probably going to see both a surge in the number of patients and an increase in the severity of disease in the near future.

[Darren Schneider, MD @VascularMD]

We’ve definitely experienced this - less urgent and emergent vascular volume during the pandemic. Our patients are scared. https://t.co/Gxur0tT0ch

[Foundation to Advance Vascular Cures @VascularCures]

The Wylie Scholar Program for promising young vascular surgeon-scientists in North America is open for applications. The award is designed for those combining their clinical practice with innovative academic research. For details, visit our website at https://t.co/wah2FfLcxk.

[Ed Yu @edkyu2]

Well put. Equality includes both representation and access.

[Bob Kain @bob_kain]

There is a growing awareness & movement in the right direction.
Bringing equality to data ownership, usage, and storage “is ultimately & fundamentally about control, not only about who controls democracy, but also who controls your daily life.”
@LunaDNA_
https://t.co/2p6nZvYHOQ

[Foundation to Advance Vascular Cures @VascularCures]

Our #patientspotlight is Sam Persey.

Sadly, Sam was one of the millions of people who don't know they have PAD and suffer an avoidable amputation. Often asymptomatic, patients are easily misdiagnosed or not at all.

Learn more at: https://t.co/3HK7fAkiRo.

[Oliver Aalami @DrAalami]

Need to do a better job at utilizing Supervised Exercise Therapy for peripheral artery disease (PAD) - excited about home based education/therapy coming soon to address the barriers https://t.co/88zMPNzDPk

[Foundation to Advance Vascular Cures @VascularCures]

#PAD is a leading cause of amputations. Yet, it's often undetected due to lack of screening and patient-familiarity with the disease. In honor of #PADawareness month, go to https://t.co/3HK7fAkiRo to find out if you are at risk, and how to support patients and our mission.